文献速递儿科影像技术与安全

对儿童安全吗?放射学人工智能医疗器械忽视儿科适用性

Safe for kids? AI medical devices in radiology overlook paediatric suitability.
PubMed 文献 · Eur Radiol · 2025-10-08

该综述评估了欧洲监管批准的放射学人工智能医疗器械对儿科适用性的标注情况,发现仅2%(4/213)明确标注儿科使用,11%标注全年龄段含儿童,41%(88/213)未明确标注目标人群。进一步审查后,这些未明确设备中7%(6/88)实际纳入18岁以下患者,但47%(41/88)仍不明确。作者倡导建立标准化儿科安全指标以清晰传达适用性。

要点

  • 仅2%(4/213)的欧洲批准放射学AI器械明确标注儿科使用,11%标注全年龄段含儿童。
  • 41%(88/213)的器械未在数据库明确标注目标人群,进一步审查后47%(41/88)仍不明确。
  • 多数监管放射学AI器械缺乏儿童适用信息,存在无意超说明书使用的潜在风险。

核心结论

  • 大多数监管批准的放射学人工智能医疗器械关于儿童适用性的信息缺失或不明确,这带来了包括无意超说明书使用在内的显著潜在风险,可能危及患者安全;作者倡导建立标准化的儿科安全指标以清晰传达适用性。

研究设计与样本

  • 对来自非营利公开数据库的所有监管批准的放射学人工智能医疗器械进行全面审查,由两名独立评审员评估使用场景、模态和目标人群,第三名评审员解决分歧;当目标人群不明确时,对现有证据和营销材料进行标准化审查。

诊断标准与关键数值

  • 仅4/213(2%)的人工智能医疗器械明确标注儿科使用。
  • 另有11%的器械标注适用于所有年龄段包括儿童。
  • 大多数(88/213;41%)的器械未在数据库中明确展示其目标人群。
  • 对88个「不明确」器械的进一步审查显示,6个(6/88,7%)在目标人群中纳入18岁以下患者,但47%(41/88)在进一步审查后仍不明确。

临床应用与阅片要点

  • 作者倡导建立标准化的儿科安全指标,以清晰传达放射学人工智能医疗器械对儿童的适用性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: Prior publications have highlighted inconsistent labelling of intended use cases and target population for U.S. Food and Drug Administration-approved AI medical devices, especially for children. The extent to which this issue applies to devices within Europe remains unaddressed.

MATERIALS AND METHODS: A comprehensive review was conducted of all regulatory-approved AI medical devices for use in radiology from a non-profit, publicly available database. Two independent reviewers assessed information about all the devices regarding use case, modality and intended population. A third reviewer resolved any discrepancies. Where the intended population was unclear, a standardised review of the available evidence and marketing materials for the AI device was conducted.

RESULTS: Only four (4/213, 2%) AI medical devices were clearly labelled for paediatric use. A further 11% were intended for all ages, including children. The majority (88/213; 41%) of all AI medical devices did not clearly demonstrate their intended population on the database. Further examination of the scientific literature and marketing of these "unclear" devices showed that 6 (6/88, 7%) of these included patients under 18 in their intended target population, but 47% (41/88) still remained unclear after further review.

CONCLUSION: Most regulated radiology AI medical devices have missing or unclear information regarding the appropriate use in children. This poses significant potential risk, including inadvertent off-label use, which could compromise patient safety. The EU AI Act emphasises the need for transparency and accountability in AI device deployment, and we therefore advocate for a standardised paediatric safety indicator to clearly communicate suitability.

KEY POINTS: Question To what extent do European-approved radiology AI devices provide clear labelling of intended use and suitability for paediatric populations? Findings Many radiology AI medical devices in Europe lack explicit paediatric use information, raising concerns about unintended off-label use. Clinical relevance Clear labelling of AI device suitability for children is essential to ensure safe use. A standardised safety indicator could aid clinicians in appropriate device selection.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Kelly BS, Lee J, Antram E, et al. Safe for kids? AI medical devices in radiology overlook paediatric suitability. Eur Radiol. 2025. PMID: 41060417. doi:10.1007/s00330-025-11975-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。